Native cellular fluorescence identifies terminal squamous differentiation of normal oral epithelial cells in culture: A potential chemoprevention biomarker Journal Article


Authors: Sacks, P. G.; Savage, H. E.; Levine, J.; Kolli, V. R.; Alfano, R. R.; Schantz, S. P.
Article Title: Native cellular fluorescence identifies terminal squamous differentiation of normal oral epithelial cells in culture: A potential chemoprevention biomarker
Abstract: Native cellular fluorescence (NCF) is being investigated as an intermediate endpoint biomarker for chemoprevention. Oral epithelial cells were cultured under three conditions to identify a spectral pattern for epithelial differentiation: cells maintained in serum-free keratinocyte growth medium were the least differentiated (KGM cells); cells switched to DMEM/F12 plus 10% FCS were intermediate in differentiation (DMEM/F12/FCS cells); DMEM/F12/FCS cells switched to serum-free DMEM/F12 plus 0.8 M NaCl to induce cornified envelopes were the most differentiated (DMEM/F12/NaCl cells). The differentiation status was characterized using immunohistochemistry and electron microscopy. NCF analysis was able to distinguish terminally differentiated epithelial cells (DMEM/F12/NaCl) from those less differentiated cells (KGM, DMEM/F12/FCS) in several emission (λ(ex) 340 nm, λ(em), 360-660 nm; λ; 365 nm, λ, 400-700 nm; λ(em) 420 nm, λ(em) 440-800 nm) and excitation scans (λ(em) 200-360 nm; λ(em) 380 nm, λ(em) 240-430 nm; λ(em) 450 nm,; λ 250-460 nm, λ 480 nm; λ 270-500 nm, λ 520 nm). The ability to discriminate terminal differentiation in this in vitro model supports the concept of using NCF as an intermediate biomarker to monitor in vivo mucosal differentiation.
Keywords: immunohistochemistry; human tissue; human cell; electron microscopy; chemoprophylaxis; cell differentiation; cell culture; biomarker; fluorescence spectroscopy; cell marker; mouth mucosa; fluorescence analysis; differentiation; chemoprevention; squamous epithelium; human; priority journal; article; oral epithelial cells
Journal Title: Cancer Letters
Volume: 104
Issue: 2
ISSN: 0304-3835
Publisher: Elsevier Ireland Ltd.  
Date Published: 1996-07-12
Start Page: 171
End Page: 181
Language: English
DOI: 10.1016/0304-3835(96)04246-2
PUBMED: 8665485
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 22 November 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Peter G Sacks
    53 Sacks
  2. Stimson P Schantz
    115 Schantz
  3. Howard Savage
    29 Savage